Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The optimal blood pressure reduction

L Hansson1

  • 1Department of Geriatrics, University of Uppsala, Sweden.

Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension
|September 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

Lancet (London, England)·2000
Same author

Operations for extrahepatic bile duct cancers: are the results really improving?

The European journal of surgery = Acta chirurgica·2000
Same author

Blood pressure @ Internet-www.bloodpressure.nu.

Blood pressure·2000
Same author

Study on COgnition and Prognosis in the Elderly (SCOPE): baseline characteristics.

Blood pressure·2000
Same author

Endothelial dysfunction--a challenge for hypertension research.

Blood pressure·2000
Same author

Introduction: the role of combination therapy in modern antihypertensive therapy.

Journal of cardiovascular pharmacology·2000
Same journal

Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Hypertension and kidney alterations in rat offspring from low protein pregnancies.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Comparison of the effects of indapamide and captopril on the development of spontaneous hypertension.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

The protective effect of irbesartan in rats fed a high fat diet is associated with modification of leptin-adiponectin imbalance.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Chronic antioxidant therapy fails to ameliorate hypertension: potential mechanisms behind.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
Same journal

Endothelial dysfunction in spontaneously hypertensive rats: focus on methodological aspects.

Journal of hypertension. Supplement : official journal of the International Society of Hypertension·2009
See all related articles

Achieving optimal blood pressure reduction in hypertension treatment remains a challenge. Current methods may not fully prevent cardiovascular risks, and further research is needed to determine ideal blood pressure targets.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Clinical Trials

Background:

  • Current antihypertensive treatments may not adequately reduce cardiovascular morbidity and mortality associated with arterial hypertension.
  • Treated hypertensive patients often still exhibit elevated cardiovascular risks despite ongoing treatment.
  • Explanations for residual risk include undertreatment or potential risks of excessive blood pressure lowering (J-curve effect).

Purpose of the Study:

  • To investigate the optimal blood pressure reduction for maximizing the prevention of hypertension-associated cardiovascular events.
  • To evaluate the effectiveness of current antihypertensive treatment strategies in achieving normotensive levels and reducing cardiovascular risks.
  • To explore the potential benefits and risks associated with different levels of blood pressure lowering in hypertensive patients.

Related Experiment Videos

Main Methods:

  • Review of data from prospective intervention trials, including the Swedish BBB (Treat Blood Pressure Better) study and the ongoing Hypertension Optimal Treatment (HOT) study.
  • Analysis of epidemiological data from the Framingham Heart Study and a study of 50-year-old men in Gothenburg.
  • Comparison of cardiovascular morbidity and mortality rates in treated versus untreated hypertensive populations.

Main Results:

  • Existing antihypertensive treatments have not yet fully eliminated the increased risk of cardiovascular events in treated hypertensive individuals.
  • Intervention trials suggest that blood pressure is often not reduced to strictly normotensive levels.
  • Epidemiological data indicate that active hypertension intervention may shift population blood pressure towards lower levels, potentially benefiting even untreated individuals.

Conclusions:

  • The optimal blood pressure reduction strategy for preventing cardiovascular complications in arterial hypertension requires further investigation.
  • Current treatment approaches may need refinement to achieve maximal cardiovascular risk reduction.
  • Antihypertensive interventions might have broader population-level benefits on blood pressure distribution than previously recognized.